Short answer
Tango Therapeutics, Inc. (TNGX) filed an 8-K current report with the SEC on August 11, 2026 reporting Item 8.01 (Other Events). ATM offering capacity increased to $400 million, including $35.61 million carried over from the prior prospectus.
Tango Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- ATM offering capacity increased to $400 million, including $35.61 million carried over from the prior prospectus
- Approximately $64.39 million already sold under the prior $100 million authorization
- Prior prospectus terminated; future issuance occurs under the new supplement through Leerink Partners
- Potential equity issuance creates dilution risk and provides Tango additional financing flexibility
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tango Therapeutics, Inc. 8-K filings
Get the next TNGX 8-K as it lands
Follow TNGX for push alerts, or ask the research agent what this filing means.